Labcorp Holdings Inc. (LH) Net Income CAGR:28.83%(TTM)
Net income CAGR uses precomputed financial statement history.
Over longer horizons, Labcorp Holdings Inc.'s Net Income CAGR averages -2.00% over 3 years and -18.65% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Net income CAGR shows how Labcorp Holdings Inc.'s bottom-line profitability has grown. This reflects the company's ability to convert revenue into profits after all expenses.
LH Net Income CAGR Chart
Labcorp Holdings Inc. (LH)
LH Quarterly Net Income Growth (YoY)
Net Income growth vs the same quarter one year earlier, last 20 quarters.
LH Net Income CAGR History
| Year | Start Net Income | End Net Income | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $746.00M | $876.50M | +$130.50M | +17.49% | +17.49% |
| 2024 | $418.00M | $746.00M | +$328.00M | +78.47% | +78.47% |
| 2023 | $1.28B | $418.00M | $-861.10M | -67.32% | -67.32% |
| 2022 | $2.38B | $1.28B | $-1.10B | -46.20% | -46.20% |
| 2021 | $1.56B | $2.38B | +$821.20M | +52.77% | +52.77% |
| 2020 | $823.80M | $1.56B | +$732.30M | +88.89% | +88.89% |
| 2019 | $883.70M | $823.80M | $-59.90M | -6.78% | -6.78% |
| 2018 | $1.27B | $883.70M | $-384.50M | -30.32% | -30.32% |
| 2017 | $732.10M | $1.27B | +$536.10M | +73.23% | +73.23% |
| 2016 | $436.90M | $732.10M | +$295.20M | +67.57% | +67.57% |
| 2015 | $511.20M | $436.90M | $-74.30M | -14.53% | -14.53% |
| 2014 | $573.80M | $511.20M | $-62.60M | -10.91% | -10.91% |
| 2013 | $583.10M | $573.80M | $-9.30M | -1.59% | -1.59% |
| 2012 | $519.70M | $583.10M | +$63.40M | +12.20% | +12.20% |
| 2011 | $558.20M | $519.70M | $-38.50M | -6.90% | -6.90% |
| 2010 | $543.30M | $558.20M | +$14.90M | +2.74% | +2.74% |
| 2009 | $464.50M | $543.30M | +$78.80M | +16.96% | +16.96% |
| 2008 | $476.80M | $464.50M | $-12.30M | -2.58% | -2.58% |
| 2007 | $431.60M | $476.80M | +$45.20M | +10.47% | +10.47% |
| 2006 | $386.20M | $431.60M | +$45.40M | +11.76% | +11.76% |
| 2005 | $363.00M | $386.20M | +$23.20M | +6.39% | +6.39% |
| 2004 | $321.00M | $363.00M | +$42.00M | +13.08% | +13.08% |
| 2003 | $254.60M | $321.00M | +$66.40M | +26.08% | +26.08% |
| 2002 | $179.50M | $254.60M | +$75.10M | +41.84% | +41.84% |
| 2001 | $112.10M | $179.50M | +$67.40M | +60.12% | +60.12% |
| 2000 | $65.40M | $112.10M | +$46.70M | +71.41% | +71.41% |
| 1999 | $68.80M | $65.40M | $-3.40M | -4.94% | -4.94% |
| 1998 | $-106.90M | $68.80M | +$175.70M | N/A | N/A |
| 1997 | $-153.50M | $-106.90M | +$46.60M | N/A | N/A |
Quarterly Net Income: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $277.80M | +68.7% | +30.5% |
| Q4 2025 | $164.70M | -36.9% | +14.9% |
| Q3 2025 | $261.10M | +9.8% | +54.2% |
| Q2 2025 | $237.90M | +11.8% | +15.9% |
| Q1 2025 | $212.80M | +48.4% | -6.7% |
| Q4 2024 | $143.40M | -15.3% | — |
| Q3 2024 | $169.30M | -17.5% | -7.6% |
| Q2 2024 | $205.30M | -10.0% | +8.7% |
| Q1 2024 | $228.00M | — | +7.1% |
| Q4 2023 | -$167.10M | — | — |
| Q3 2023 | $183.30M | -3.0% | -48.0% |
| Q2 2023 | $188.90M | -11.3% | -47.3% |
| Q1 2023 | $212.90M | +179.8% | -56.7% |
| Q4 2022 | $76.10M | -78.4% | -86.2% |
| Q3 2022 | $352.80M | -1.6% | -39.9% |
| Q2 2022 | $358.60M | -27.1% | -23.3% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter